GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Daptomycin

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Cubicin - UCSF Infectious Diseases Management Program

Product / population
UCSF adult daptomycin protocol, institutional high-dose use.
Renal method
Intermittent HD or CVVHD with specified flow and dosing weight.
Source revision
Online guidance checked 2026-11-07; section revision not established.
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Do not merge label and higher-dose institutional dialysis protocols

The label includes CrCl exactly 30 in its >=30 band. UCSF prints >30 and <30, omitting exactly 30, and uses higher doses and different HD scheduling.

What to reconcile: Keep source-specific dose, interval, indication, weight basis and modality together. The official threshold is explicit; seek institutional clarification rather than silently changing its headings.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references

Cubicin - product and source limitations

The labeled adult doses for cSSSI and S. aureus bacteremia differ from UCSF institutional high-dose regimens. Check infection, weight convention and dialysis modality.

What to reconcile: The labeled adult doses for cSSSI and S. aureus bacteremia differ from UCSF institutional high-dose regimens. Check infection, weight convention and dialysis modality.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Professional

Cubicin - UCSF Infectious Diseases Management Program

Open original reference

UCSF Infectious Diseases Management Program · UCSF adult daptomycin protocol, institutional high-dose use.

Renal method: Intermittent HD or CVVHD with specified flow and dosing weight.
Source date: Online guidance checked 2026-11-07; section revision not established.
Retrieved: 2026-11-07

Professional guidance with defined scope. Publication date, institutional setting and source limitations remain controlling. This is not automatic preference over another source.

Selected renal passages reviewed; independent clinician adjudication pending.

Dosing weights and hemodialysis

For intermittent HD, UCSF uses 8-10 mg/kg IV initially and after HD, with every-48-hour dosing as an alternative for an unstable dialysis schedule. For CVVHD it lists 6-8 mg/kg IV every 24 hours; flow above 2.5 L/hour can require specialist-guided changes. Use total weight unless it exceeds 120% of ideal, when UCSF uses adjusted weight. Other CRRT modes were not evaluated.

RDM73-cubicin-professional-1 · Source locator: Dosing weights and hemodialysis

Source identity and provenance
Source family
professional_guideline
Source
https://idmp.ucsf.edu/content/daptomycin
Retrieved
2026-11-07
Renal-function method
Intermittent HD or CVVHD with specified flow and dosing weight.
Source date/version
Online guidance checked 2026-11-07; section revision not established.
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
2845f69d596e9e26cbaa0347b59f12e551d3dc2a86fc4602845cb9abbfbbad49

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=daptomycin&s1=RDM73-cubicin-professional&h1=90b50f967b9f24749067998ec8fd58ede71e13bf25dbbf8eb7d7dd79a3a305d6

Top